Evidence map›Paper›PMID 33674905›Full record

ArticleStrahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al]2021

Correction to: Prognostic impact of gross tumor volume during radical radiochemotherapy of locally advanced non-small cell lung cancer-results from the NCT03055715 multicenter cohort study of the Young DEGRO Trial Group.

C Ostheimer, M Mäurer, N Ebert, D Schmitt, D Krug, R Baumann, C Henkenberens, F A Giordano, L Sautter, Guerra López and 19 more

Abstract readPublished Erratum
PubMed Full text at PMC Publisher
In one paragraph

Article in Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al], 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

29 authors.

C OstheimerDepartment of Radiation Oncology, Faculty of Medicine, Martin Luther University Halle-Wittenberg, Ernst-Grube-Straße 40, 06110, Halle (Saale), Germany. Christian.Ostheimer@uk-halle.de.
M MäurerDepartment of Radiation Oncology, University Medical Center Jena, Jena, Germany.
N EbertDepartment of Radiation Oncology, University Medical Center Dresden, Dresden, Germany.
D SchmittDepartment of Radiation Oncology, University Hospital Heidelberg, Heidelberg, Germany.
D KrugDepartment of Radiation Oncology, University Hospital Heidelberg, Heidelberg, Germany.
R BaumannDepartment of Radiation Oncology, University Medical Center Schleswig-Holstein, Kiel, Germany.
C HenkenberensDepartment of Radiation and Special Oncology, Hannover Medical School, Hannover, Germany.
F A GiordanoDepartment of Radiation Oncology, University Medical Center Mannheim, Mannheim, Germany.
L SautterDepartment of Radiation Oncology, University Medical Center Mannheim, Mannheim, Germany.
Guerra LópezDepartment of Radiation Oncology, Hospital Universitario Virgen del Rocío, Sevilla, Spain.
D F FleischmannDepartment of Radiation Oncology, LMU Munich, Munich, Germany.
M NiyaziDepartment of Radiation Oncology, LMU Munich, Munich, Germany.
L KäsmannDepartment of Radiation Oncology, University of Lübeck, Lübeck, Germany.
D KaulDepartment of Radiation Oncology, Charité School of Medicine, Berlin, Germany.
A H ThiemeDepartment of Radiation Oncology, Charité School of Medicine, Berlin, Germany.
C BillietDepartment of Radiation Oncology, Iridium Kankernetwerk, Antwerp, Belgium.
S DobiaschDepartment of Radiation Oncology, Technische Universität München, Munich, Germany.
C R ArnoldDepartment of Therapeutic Radiology and Oncology, Medical University of Innsbruck, Innsbruck, Austria.
M OertelDepartment of Radiation Oncology, University Medical Center Muenster, Muenster, Germany.
J HaussmannDepartment of Radiation Oncology, University Medical Center Düsseldorf, Dusseldorf, Germany.
T GauerDepartment of Radiotherapy and Radio-Oncology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
Y GoyDepartment of Radiotherapy and Radio-Oncology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
C SuessDepartment of Radiation Oncology, University Medical Center Regensburg, Regensburg, Germany.
S ZieglerDepartment of Radiation Oncology, University Medical Center Erlangen, Erlangen, Germany.
C M PanjeDepartment of Radiation Oncology, Kantonsspital St. Gallen, St. Gallen, Switzerland.
C BauesDepartment of Radiation Oncology and Cyberknife Center, University of Cologne, Cologne, Germany.
M TrommerDepartment of Radiation Oncology and Cyberknife Center, University of Cologne, Cologne, Germany.
T SkripcakGerman Cancer Research Center (DKFZ), Heidelberg, Germany.
D MedenwaldDepartment of Radiation Oncology, Faculty of Medicine, Martin Luther University Halle-Wittenberg, Ernst-Grube-Straße 40, 06110, Halle (Saale), Germany.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID33674905
PMCPMC8154766

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.